Skip to main content
Caplight Logo









Lyric Bio

Lyric Bio

Private
San Carlos, CaliforniaHealthcare & Life Scienceshttps://www.lyricbio.com/

Last Round

Seed

Dec 2, 2025

Total Funding Raised

$6.6M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Lyric Bio is a biotechnology company that is developing high-density tissue mimicking bioreactors to reduce Ig therapy dependence on human donation.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

biomanufacturinglaser bioprintingtissue engineering3D bioprintingbioreactortissue-mimicking bioreactorhigh-density cell culturehuman immunoglobulin productionB-cell culturePEC antibodiesconditionally-activated biologicstargeted cancer therapysolid tumor therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lyric Bio Comparables

Compare Lyric Bio with similar companies based on industry and business-model similarity.

Lyric Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Prellis Biologics
44%
Frontier Bio
39%
FluidForm Bio
38%

Lyric Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedDec 2, 2025

Lyric Bio Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 20, 2026

    Grew 71% QoQ from 7 to 12 employees.

  • Jan 22, 2026

    Grew 43% QoQ from 7 to 10 employees.

Lyric Bio Filings

Explore SEC and related filing metadata, where available.

Lyric Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Lyric Bio's valuation, stock price, and market status.

Is Lyric Bio a public or private company?

Lyric Bio is a private company.

What is the current stock price of Lyric Bio?

Lyric Bio is a private company with no public stock price. No recent secondary market data is available.

How much is Lyric Bio worth (valuation)?

Valuation information for Lyric Bio is not publicly available.

Can I buy Lyric Bio stock?

Lyric Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Lyric Bio's last funding round?

Lyric Bio's most recent funding round was Seed on December 2, 2025.

Who are the main investors in Lyric Bio?

Key investors in Lyric Bio include The Venture Collective.

Will Lyric Bio IPO soon?

No public IPO plans have been announced for Lyric Bio.

How can I track Lyric Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Lyric Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Carlos, California
Employee Range11
Year Founded2024
Last FundingDec 2, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?